UYSAL, C. Et Al. 2024. The utility of serum neutrophil gelatinase-associated lipocalin level on predicting autosomal dominant polycystic kidney disease progression. THERAPEUTIC APHERESIS AND DIALYSIS , vol.28, no.5 , 760-768.

UYSAL, C., Koyuncu, S., Ipekten, F., KARAKÜKCÜ, Ç., & KOÇYİĞİT, İ., (2024). The utility of serum neutrophil gelatinase-associated lipocalin level on predicting autosomal dominant polycystic kidney disease progression. THERAPEUTIC APHERESIS AND DIALYSIS , vol.28, no.5, 760-768.

UYSAL, CİHAN Et Al. "The utility of serum neutrophil gelatinase-associated lipocalin level on predicting autosomal dominant polycystic kidney disease progression," THERAPEUTIC APHERESIS AND DIALYSIS , vol.28, no.5, 760-768, 2024

UYSAL, CİHAN Et Al. "The utility of serum neutrophil gelatinase-associated lipocalin level on predicting autosomal dominant polycystic kidney disease progression." THERAPEUTIC APHERESIS AND DIALYSIS , vol.28, no.5, pp.760-768, 2024

UYSAL, C. Et Al. (2024) . "The utility of serum neutrophil gelatinase-associated lipocalin level on predicting autosomal dominant polycystic kidney disease progression." THERAPEUTIC APHERESIS AND DIALYSIS , vol.28, no.5, pp.760-768.

@article{article, author={CİHAN UYSAL Et Al. }, title={The utility of serum neutrophil gelatinase-associated lipocalin level on predicting autosomal dominant polycystic kidney disease progression}, journal={THERAPEUTIC APHERESIS AND DIALYSIS}, year=2024, pages={760-768} }